Sunday, June 7, 2026
NewsezeNews with Rewards · Earn while you read
+5 credits / query
health

Opinion: I led the U.S. CDC response to the 2014 Ebola epidemic. The new outbreak needs massive, immediate, meticulous action

Newseze Wire·Sat, Jun 6, 8:30 AMWire: STAT News
Open original source Read full story (in-site)
Opinion: I led the U.S. CDC response to the 2014 Ebola epidemic. The new outbreak needs massive, immediate, meticulous action

“Ebola is an unforgiving enemy,” writes Tom Frieden, who led the U.S. CDC response to the 2014-2016 Ebola outbreak.

Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by STAT News; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.

Newseze Analysis82 words · original commentary · full read loading…
“Ebola is an unforgiving enemy,” writes Tom Frieden, who led the U.S. CDC response to the 2014-2016 Ebola outbreak. The story falls into Newseze's health desk and is being actively tracked by our editorial team. Calm framing, primary-source references, and respectful tone — every Newseze story is scored for drama and conspiracy before it reaches you. Worth knowing: Newseze refreshes its newsroom every hour and flags fast-moving local and breaking news as it develops. Watch this page for updates. Reporting: STAT News.

Across the aisle

Same story · other lanes

Here's how the same story is being covered by outlets in other lanes. Read both — Newseze doesn't pick a side.

All lanes still pass Newseze's calm filters (no drama, no conspiracy, respect baseline).
Reader CommentsBe the first reader · Subscribe to join

No comments yet. Be the first.

Related stories

Triple-receptor obesity drug shows promise in monthly dosing; ADA conference reveals emerging treatment landscape
HEALTHtrust 79
Triple-receptor obesity drug shows promise in monthly dosing; ADA conference reveals emerging treatment landscape

Why it mattersNew obesity medications with longer dosing intervals could reshape treatment options for millions of Americans struggling with weight management, while competitive advances in hormonal therapies signal rapid innovation i…

You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference in New Orleans.

ChellaBy Chella·10h ago
WireSTAT News
New Triple-Hormone Obesity Drug Offers Monthly Dosing; Researchers Report Mixed Results at ADA Conference
HEALTHtrust 64
New Triple-Hormone Obesity Drug Offers Monthly Dosing; Researchers Report Mixed Results at ADA Conference

Why it mattersThe obesity treatment landscape is shifting toward longer-acting formulations that could improve patient adherence, though the mixed outcomes signal ongoing challenges in meeting weight-loss targets across diverse popula…

You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference in New Orleans.

ChellaBy Chella·10h ago
WireSTAT News